1994
DOI: 10.1097/00001756-199408150-00021
|View full text |Cite
|
Sign up to set email alerts
|

Herpes simplex virus 1 (HSV-1) helper co-infection affects the distribution of an amplicon encoded protein in glia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
10
0

Year Published

1995
1995
2006
2006

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(11 citation statements)
references
References 0 publications
1
10
0
Order By: Relevance
“…Amplicon vector stocks were prepared as already described (Lowenstein et al . 1994) using the amplicon plasmids (Fig.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Amplicon vector stocks were prepared as already described (Lowenstein et al . 1994) using the amplicon plasmids (Fig.…”
Section: Methodsmentioning
confidence: 99%
“…Amplicon vector stocks were prepared as already described (Lowenstein et al 1994) using the amplicon plasmids ( Fig. 1a), and the highly neuroattenuated HSV-1 LaL virus as helper (Logvinoff & Epstein 2000).…”
Section: Amplicon Vectorsmentioning
confidence: 99%
“…The possibility to amplify the transgene expression may allow the dose of the therapeutic vector to be lowered, minimizing a possible intrinsic toxic effect, as reported in the literature for other vectors. This study shows that amplicon-mediated delivery of anti-BKVT siRNA can inhibit T-Ag expression and growth of 26 The number of living cells was determined in triplicate samples at 24, 48 and 72 h after transduction by Trypan blue staining. Compared to controls, the growth rate of pRPc cells was markedly reduced by the pA-shBKVT-GFP amplicon vector in a dose-dependent manner.…”
Section: Hsv-1 Amplicon Vector For Sirna Transfer S Sabbioni Et Almentioning
confidence: 91%
“…In in vitro experiments, pRPc cells were either non-transduced, transduced with the pA-shBKVT-GFP amplicon or with the empty control amplicon pA-EUA, derived from the pA-SF1 amplicon plasmid. 26 The cell number was determined at 24, 48 and 72 h post-transduction, using a MOT ranging from 0.5 to 5. In comparison with control amplicon or non-transduced cells, the cellular growth rate was reduced in a dose-dependent manner in cells infected by pA-shBKVT-GFP amplicon vector ( Figure 4a).…”
mentioning
confidence: 99%
“…Compared to the parental MoMLV genome, these GPE transcription units lacked primer binding sites and polypurine tracts, both long terminal repeats (LTRs), and the packaging sequence E. This design of this defective-retrovirus genome was adopted to abolish or minimize its packaging, reverse transcription (RT), and integration. Each transcription unit was then cloned into a plasmid containing one HSV-1 origin of replication (ori-S) and one HSV-1 packaging signal ("a") (23). The resulting amplicon plasmids were called pA-TK-GPE, pA-IE3-GPE, and pA-CMV-GPE.…”
mentioning
confidence: 99%